Yarrow Bioscience (YARW) Treasury Shares (2016 - 2025)
Yarrow Bioscience's (YARW) quarterly Treasury Shares came in at $450916.0 in Q4 2025, down 39.94% YoY from $750715.0 in Q4 2024, and down 39.94% on a QoQ basis from $750715.0 in Q4 2024.
Yarrow Bioscience (YARW) Treasury Shares (2016 - 2025) Analysis & Trends
Yarrow Bioscience (YARW) has 7 years of Treasury Shares data on file, last reported at $450916.0 in Q4 2025.
- Quarterly Treasury Shares fell 39.94% year-over-year to $450916.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $450916.0 (down 39.94% YoY) and the FY2025 annual result came in at $450916.0, down 39.94% from the prior year.
- Treasury Shares eased to $450916.0 in Q4 2025, from $750715.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $750715.0 in Q4 2024 to a low of $3000.0 in Q4 2022.
- A 4-year average of $416402.5 and a median of $455947.5 in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares jumped 15265.97% — and 2025, when it slumped 39.94%.
- Tracing YARW's Treasury Shares over 4 years: stood at $3000.0 in 2022, then jumped by 15265.97% to $460979.0 in 2023, then jumped by 62.85% to $750715.0 in 2024, then tumbled by 39.94% to $450916.0 in 2025.
- The last three Treasury Shares figures came in at $450916.0 (Q4 2025), $750715.0 (Q4 2024), and $460979.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 8.96 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 2.72 Mn |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 450,916.00 |
| Dec 31, 2025 | 450,916.00 |
| Dec 31, 2024 | 750,715.00 |
| Dec 31, 2024 | 750,715.00 |
| Dec 31, 2023 | 460,979.00 |
| Dec 31, 2023 | 460,979.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2019 | 91,058.00 |
| Dec 31, 2019 | 91,058.00 |
| Dec 31, 2017 | 11.85 Mn |
| Dec 31, 2017 | 11.85 Mn |
| Dec 31, 2016 | 14.11 Mn |
| Dec 31, 2016 | 14.11 Mn |